Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingenutra is a biotechnology company specializing in the discovery and development of precision natural products for metabolic health and longevity. The company employs a proprietary multi-omics platform to identify bioactive compounds from botanical sources that target specific biological pathways involved in muscle maintenance and aging. Their primary focus is on addressing sarcopenia and age-related muscle atrophy through interventions that enhance mitochondrial function and protein synthesis. By integrating high-resolution molecular profiling with traditional natural product chemistry, Ingenutra seeks to create a new class of scientifically validated health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingenutra.